NCT07717268
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07717268
Title Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients. (OLIGORESIST)
Acronym OLIGORESIST
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries ESP


No variant requirements are available.